With its teleconsultation platform intact, revoking MaNaDr’s licence could have little impact
Telemedicine revenue accounts for about US$12.8 million or 90.4% of its parent company’s total sales
JUST days before Christmas, MaNaDr Clinic unwrapped a lump of coal in its stocking – confirmation that the healthcare provider’s licence to offer medical services in Singapore had been revoked.
The news was not entirely unexpected. The writing had been on the wall since Oct 24, when the Ministry of Health (MOH) first announced its intention to strip MaNaDr of its licence.
The intervening period up to last Friday (Dec 20) allowed the company to present its case to the ministry, outlining why it had fallen short, while MOH deliberated its fate.
TRENDING NOW
Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
HDB reviewing ‘jumbo’ flat scheme after Telok Blangah unit listed for sale at S$2.18m
What role can Japan play in Asean’s future?
